The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus

Maarten J. Postma*, Dick de Zeeuw

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

12 Citations (Scopus)
377 Downloads (Pure)
Original languageEnglish
Pages (from-to)2975-2983
Number of pages9
JournalNephrology Dialysis Transplantation
Volume24
Issue number10
DOIs
Publication statusPublished - Oct-2009

Keywords

  • chronic kidney disease
  • diabetic nephropathy
  • economics
  • proteinuria
  • CHRONIC KIDNEY-DISEASE
  • BLOOD-PRESSURE CONTROL
  • ANGIOTENSIN SYSTEM INHIBITION
  • COST-EFFECTIVENESS ANALYSIS
  • NEPHROPATHY TRIAL IDNT
  • MULTIFACTORIAL INTERVENTION
  • RANDOMIZED-TRIAL
  • CARDIOVASCULAR MORBIDITY
  • MICROVASCULAR OUTCOMES
  • ARTERIAL-HYPERTENSION

Cite this